Biospace
Published September 21, 2026
Dr. Maximilian Doebler appointed Chief Executive Officer of HMNC Brain Health as ... - BioSpace
Read the full story at Biospace
Lead asset Ketabon (KET01), partnered with MEDICE for European commercialization, is an oral prolonged-release ketamine formulation for TRD, designed.
Surfaced by this Google Alert
- Ketamine
